Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS)

222 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 183 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 97,195,653 shares of 105,670,220 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include GILEAD SCIENCES, INC. (31,424,760 shares), BlackRock, Inc. (10,867,091 shares), VANGUARD GROUP INC (6,687,800 shares), Woodline Partners LP (5,127,304 shares), FMR LLC (4,456,846 shares), STATE STREET CORP (3,696,479 shares), Point72 Asset Management, L.P. (2,867,097 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2,560,904 shares), DIMENSIONAL FUND ADVISORS LP (1,722,083 shares), and BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1,628,019 shares).
This table shows the top 183 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.